Camp4 Therapeutics's Cash & cash equivalent grew by 44.13 % in the Q3 2026 sequentially, faster than Current Liabilities, this led to improvement in Camp4 Therapeutics's Quick Ratio to 6.27, above Camp4 Therapeutics Corporation average Quick Ratio.

Within Major Pharmaceutical Preparations industry 161 other companies have achieved higher Quick Ratio than Camp4 Therapeutics in third quarter 2026. While Quick Ratio total ranking has improved so far during the Q3 2026 to 741, from total ranking in the second quarter 2026 at 784.

Explain Quick Ratio?
How much Cash & cash equivalents CAMP�s has?
What are CAMP�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CAMP/financial-strength

https://api.csimarket.com/api/v1/companies/CAMP/fundamentals

https://api.csimarket.com/api/v1/companies/CAMP/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

CAMP Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	327.2 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	65.47 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	6.27	Subscribe	Subscribe	Subscribe	Subscribe
CAMP's Total Ranking	# 741	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	3.78 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	44.13 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 162
Healthcare Sector	# 259
Overall Market	# 700

Quick Ratio Statistics
High	Average	Low
16.18	2.43	0.19
(Sep 30 2025)		(Feb 28 2011)

Financial Statements
Camp4 Therapeutics's Current Liabilities	$ 20 Millions	Visit CAMP's Balance sheet
Camp4 Therapeutics's Cash & cash equivalent	$ 125 Millions	Visit CAMP's Balance sheet
Source of CAMP's Sales		Visit CAMP's Sales by Geography

Cumulative Camp4 Therapeutics's Quick Ratio

CAMP's Quick Ratio for the trailling 12 Months

CAMP Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	230.15 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	83.04 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	5.9	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 3481	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	27.2 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	13.3 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to CAMP Financial Strength Comparisons >> Go to Compare CAMP Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q3 2026 to $19.87 millions, cumulative Quick Ratio decreased to 5.9 above the CAMP average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 417 other companies have achieved higher Quick Ratio than Camp4 Therapeutics. While Quick Ratio overall ranking has improved so far to 3481, from total ranking during the twelve months ending second quarter 2026 at 3540.

Explain Quick Ratio?
How much Cash & cash equivalents CAMP�s has?
What are CAMP�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 418
Healthcare Sector	# 853
Within the Market	# 3481

trailing twelve months Quick Ratio Statistics
High	Average	Low
7.34	1.52	0.24
(Dec 31 2025)		(Aug 31 2012)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Major Pharmaceutical Preparations Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Arrivent Biopharma inc	16.86	$ 393.691 Millions	$ 23.357 Millions
Keros Therapeutics Inc	16.36	$ 259.464 Millions	$ 15.858 Millions
Design Therapeutics Inc	16.36	$ 208.608 Millions	$ 12.753 Millions
Whitehawk Therapeutics Inc	16.25	$ 169.672 Millions	$ 10.441 Millions
Palvella Therapeutics Inc	15.85	$ 236.680 Millions	$ 14.928 Millions
Avalo Therapeutics Inc	15.63	$ 392.966 Millions	$ 25.135 Millions
Bioage Labs Inc	14.91	$ 283.637 Millions	$ 19.027 Millions
Damora Therapeutics Inc	14.72	$ 528.478 Millions	$ 35.892 Millions
Protagonist Therapeutics inc	14.42	$ 800.064 Millions	$ 55.464 Millions
Praxis Precision Medicines Inc	14.20	$ 745.323 Millions	$ 52.498 Millions
Tenax Therapeutics Inc	13.61	$ 113.700 Millions	$ 8.355 Millions
Corvus Pharmaceuticals Inc	13.25	$ 204.252 Millions	$ 15.418 Millions
Stablecoin Development Corporation	13.01	$ 7.153 Millions	$ 0.550 Millions
Uniqure N v	12.78	$ 768.430 Millions	$ 60.142 Millions
Rhythm Pharmaceuticals Inc	12.62	$ 320.944 Millions	$ 25.438 Millions
Dyne Therapeutics Inc	12.53	$ 1,134.386 Millions	$ 90.545 Millions
Sensei Biotherapeutics Inc	12.44	$ 174.795 Millions	$ 14.049 Millions
Spyre Therapeutics Inc	12.24	$ 82.727 Millions	$ 6.760 Millions
Edgewise Therapeutics inc	12.10	$ 1,743.893 Millions	$ 144.106 Millions
Structure Therapeutics Inc	11.62	$ 1,244.661 Millions	$ 107.104 Millions
Immunome Inc	11.27	$ 461.582 Millions	$ 40.966 Millions
Korro Bio Inc	11.06	$ 165.015 Millions	$ 14.923 Millions
Xenon Pharmaceuticals Inc	10.99	$ 950.798 Millions	$ 86.487 Millions
Newamsterdam Pharma Company N v	10.99	$ 628.242 Millions	$ 57.154 Millions
Vtv Therapeutics Inc	10.99	$ 77.164 Millions	$ 7.024 Millions
Abcellera Biologics Inc	10.85	$ 764.424 Millions	$ 70.473 Millions
Cogent Biosciences Inc	10.82	$ 791.134 Millions	$ 73.118 Millions
Bicycle Therapeutics Plc	10.57	$ 469.928 Millions	$ 44.459 Millions
Lipocine Inc	10.55	$ 21.455 Millions	$ 2.034 Millions
Cyclerion Therapeutics Inc	10.32	$ 456.221 Millions	$ 44.197 Millions

Date modified: 2026-11-06T06:34:55+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.